![Logo](/assets/logo-d3f1fdf60522f0983e71f9fcc720cb7da5b55c0b748ed5bded3d2fbf81387bf0.png)
CORD-19:cb16d307afaecebd683e6d74c8b501ed54b0c9a4 / 20914-21168
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/cb16d307afaecebd683e6d74c8b501ed54b0c9a4","sourcedb":"CORD-19","sourceid":"cb16d307afaecebd683e6d74c8b501ed54b0c9a4","text":"In 2012, according to the theory of Structure-Based Drug Design, Norman and co-workers [52] designed and synthesized a series of class II c-Met inhibitors, among which derivative 67 ( Fig. 6 ) was confirmed to possess excellent potency against c-Met (Ki:","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T119","span":{"begin":0,"end":254},"obj":"Sentence"},{"id":"T8996","span":{"begin":0,"end":254},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T119","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T8996","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T119","span":{"begin":0,"end":254},"obj":"Sentence"}],"attributes":[{"subj":"T119","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#baec93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec93d4"}]}]}}